American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

$Protagenic Therapeutics, Inc.\new logo$

Protagenic Therapeutics, Inc.\new (PTIX)

$0.22 -17.17% OTC: PTIX · 15-min delayed

NEW YORK, New York
Public · OTC: PTIX

Visit website Follow

$0Revenue · FY2024

-$5.5MNet income

PTIXOTC

About Protagenic Therapeutics, Inc.\new

PROTAGENIC THERAPEUTICS

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: PTIX
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: PTIX OTC
SEC CIK: 1022899
EIN: 061390025
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Protagenic Therapeutics, Inc.\new’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/protagenic-therapeutics-incnew/"><img src="https://americancompanies.com/badge/protagenic-therapeutics-incnew.svg" alt="Protagenic Therapeutics, Inc.\new — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Protagenic Therapeutics, Inc.\new and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2024: $0
Net income: -$5.5M
Total assets: $2.0M

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

FY2021

FY2022

FY2023

FY2024

Revenue Net income

FY 2024

Financial statements

Income statement

Revenue: $0
Operating expenses: $5.7M
Operating income: -$5.7M
Net income: -$5.5M
EPS (basic): $-1.13
EPS (diluted): $-1.13

Balance sheet

Total assets: $2.0M
Current assets: $1.9M
Total liabilities: $942.8K
Current liabilities: $942.8K
Shareholders’ equity: $1.0M

Cash flow

Operating cash flow: -$4.2M
Investing cash flow: $2.8M
Financing cash flow: $1.4M
Net cash flow: $0

Statements via Polygon.io (SEC filings)

OTC: PTIX

$0.22 -17.17%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.19 $4.51

52-week range

EPS (diluted): $-1.13
Open: —
Day range: –
Prev close: —
Volume: —

Protagenic Therapeutics, Inc.\new (PTIX) Stock Price

Reported a net loss of $5.5M in FY2024.
Trading 95% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Protagenic Therapeutics, Inc.\new.

Write a review

Newsroom

News about Protagenic Therapeutics, Inc.\new

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Benzinga · 2023-03-23 Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session Benzinga · 2022-12-30 Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET GlobeNewswire Inc. · 2021-08-30 Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update GlobeNewswire Inc. · 2021-08-17 Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial GlobeNewswire Inc. · 2021-07-23 12 Health Care Stocks Moving In Monday's Pre-Market Session Benzinga · 2021-06-07

News & sentiment via Polygon.io

FAQ

Protagenic Therapeutics, Inc.\new: frequently asked questions

Is Protagenic Therapeutics, Inc.\new an American company?

Protagenic Therapeutics, Inc.\new is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Protagenic Therapeutics, Inc.\new headquartered?

Protagenic Therapeutics, Inc.\new is headquartered in New York, New York, United States.

Is Protagenic Therapeutics, Inc.\new publicly traded?

Yes — Protagenic Therapeutics, Inc.\new is a publicly traded company. Its stock trades under the ticker symbol PTIX on the OTC.

What does Protagenic Therapeutics, Inc.\new do?

Protagenic Therapeutics, Inc.\new is an American Pharmaceuticals company in the Health & Beauty sector.

Explore